| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.76B | -1.6% |
| Cost of Revenue | $2.81B | -7.5% |
| Gross Profit | $942.0M | +21.4% |
| R&D Expense | $44.0M | +15.8% |
| SG&A Expense | $430.0M | +26.5% |
| Interest Expense | $119.0M | +56.6% |
| Pre-tax Income | $393.0M | +16.3% |
| Income Tax | $95.0M | +18.8% |
| Net Income | $298.0M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $115.0M | +202.6% |
| Accounts Receivable | $347.0M | -0.3% |
| Inventory | $524.0M | -27.4% |
| Current Assets | $1.04B | -11.1% |
| Total Assets | $4.78B | -3.0% |
| Current Liabilities | $478.0M | -3.6% |
| Long-term Debt | $1.83B | -12.4% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $644.0M | +194.1% |
| Capital Expenditures | $104.0M | -18.8% |
| Investing Cash Flow | -$110.0M | +14.1% |
| Financing Cash Flow | -$457.0M | -110.6% |
| Free Cash Flow | $540.0M | +493.4% |
| +15.5% |
| EPS (Basic) | $1.42 | +15.4% |
| EPS (Diluted) | $1.42 | +15.4% |
| Total Liabilities |
| $2.80B |
| -8.6% |
| Stockholders' Equity | $1.98B | +6.2% |